According to a market report by Lucintel, the future of the global non-invasive cancer diagnostic market looks promising with opportunities in the solid tumors, blood cancer, lung cancer, and breast cancer markets. The global non-invasive cancer diagnostic market is expected to reach an estimated $199.2 billion by 2030 with a CAGR of 6.8% from 2024
Lucintel Forecasts the Global Colorectal Cancer Diagnostic Market to Reach $33.8 billion by 2030
According to a market report by Lucintel, the future of the global colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets. The global colorectal cancer diagnostic market is expected to reach an estimated $33.8 billion by 2030 from $21.
Lucintel Forecasts the Global Brain Cancer Diagnostic Market to reach $9.3 billion by 2030
According to a market report by Lucintel, the future of the global brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets. The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030 with
Lucintel Forecasts the Global Liver Cancer Diagnostic Market to Reach $11.0 billion by 2030
According to a market report by Lucintel, the future of the global liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets. The global liver cancer diagnostic market is expected to reach an estimated $11.0 billi
Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 billion by 2030
According to a market report by Lucintel, the future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.